Skip to main content

Table 4 Estimated Percentage of Diabetic BMS Patients Likely to Receive DES by Year Following DES Approval

From: Changing treatment patterns for coronary artery revascularization in Canada: the projected impact of drug eluting stents

  Mean Median Min Max # of Panel Members Responding
% of Diabetic Bare Metal Stent Patients Receiving DES, 1st Year Following Approval
all patients 43.2% 40.0% 10.2% 90.0% 11
all patients with single-vessel 39.5% 30.0% 10.2% 80.0% 9
all patients with multi-vessel 61.4% 50.0% 30.0% 100.0% 7
% of Diabetic Bare Metal Stent Patients Receiving DES, 2nd Year Following Approval
all patients 60.6% 60.0% 25.5% 100.0% 11
all patients with single-vessel 57.9% 50.0% 25.5% 100.0% 9
all patients with multi-vessel 75.0% 75.0% 40.0% 100.0% 7
% of Diabetic Bare Metal Stent Patients Receiving DES, 3rd Year Following Approval
all patients 77.9% 80.0% 50.0% 100.0% 11
all patients with single-vessel 75.7% 80.0% 50.0% 100.0% 9
all patients with multi-vessel 81.4% 80.0% 50.0% 100.0% 7
% of Diabetic Bare Metal Stent Patients Receiving DES, 4th Year Following Approval
all patients 86.1% 90.0% 60.0% 100.0% 11
all patients with single-vessel 85.2% 90.0% 60.0% 100.0% 9
all patients with multi-vessel 87.1% 90.0% 60.0% 100.0% 8
% of Diabetic Bare Metal Stent Patients Receiving DES, 5th Year Following Approval
all patients 90.9% 90.0% 70.0% 100.0% 11
all patients with single-vessel 88.0% 90.0% 70.0% 100.0% 10
all patients with multi-vessel 89.0% 90.0% 70.0% 100.0% 10